Research Trial

Amgen Protocol 20080560 -This study may reduce bone loss for patients who are on hormone therapy for Prostate Cancer.

Some Requirements:

• Men over 30 years of age with non- metastatic prostate cancer.
• Had a bilateral orchiectomy or started hormone therapy and will continue for 1 year.

Sponsored by: Amgen
Length of Study: 12 months
Enrollment: Open

Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.

Tonya Godfrey, R.N., Clinical Research Coordinator (315) 706-8112
Mark Chilton, Clinical Research Coordinator (315) 396-1729
Melissa Clark, R.N., Clinical Research Coordinator (315) 363-9523 

Our Principal Investigators are: David M. Albala, M.D., Joel S. Bass, M.D., Bashar Omarbasha, M.D.